文献速递精神分裂症与精神病性障碍心境障碍

抗精神病药突触后密度蛋白的分子与拓扑映射:动物模型荟萃分析及转化意义

Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications.
PubMed 文献 · Mol Psychiatry · 2025-11-19

该荟萃分析系统汇总81项临床前研究(n=2542),评估典型与非典型抗精神病药对突触后密度(PSD)蛋白的定量影响。结果显示药物因受体特征、剂量、蛋白类型、脑区和给药方案不同而差异调节PSD分子,如氟哌啶醇、氨磺必利、阿立哌唑显著升高纹状体PSD蛋白,奥氮平急性与慢性效应相反,氯氮平升高Homer1a及NMDAR亚基。

要点

  • 抗精神病药对PSD蛋白的调节具有脑区、蛋白类型和给药方案特异性。
  • 氟哌啶醇、氨磺必利、阿立哌唑显著增加纹状体PSD蛋白表达。
  • 奥氮平急性与慢性给药对纹状体和前额叶Arc表达效应相反。

核心结论

  • 典型与非典型抗精神病药均调节PSD分子,但程度因药物受体特征、剂量、检测蛋白、脑区和给药方案而异。

研究设计与样本

  • 系统综述与随机效应模型荟萃分析,纳入81项临床前研究(n=2542;啮齿类2510,猴26),共226项荟萃分析。

主要发现

  • 氟哌啶醇、氨磺必利和阿立哌唑显著增加纹状体PSD蛋白表达。
  • 急性奥氮平升高纹状体PSD分子水平,降低前额叶Arc表达(SMD [95%CIs]=-2.15 [-2.7;-1.61],p < 0.0001),慢性治疗效应相反。
  • 氯氮平升高背侧纹状体Homer1a(1.13 [0.41;1.86],p = 0.002)、腹侧纹状体Homer1a(1.48 [0.72;2.24],p = 0.0001)和扣带皮层Homer1a(2.12 [1.12;3.12],p < 0.0001),并升高前额叶NMDAR亚基水平。

关键数值与推荐

  • 纳入同行评议的临床前研究,报告典型与非典型抗精神病药对PSD相关结局的定量效应。
  • 采用随机效应模型,异质性通过τ²、I²和Cochran's Q评估,并按PSD蛋白类型、脑区、动物类型和治疗范式分别进行荟萃分析。
  • 使用荟萃回归评估混杂变量的影响。

临床怎么用

  • 提示抗精神病药的突触效应具有脑区与蛋白选择性,可为药物选择和机制研究提供临床前依据。
  • 奥氮平急慢性效应相反,提示临床用药时长可能影响突触蛋白结局。

局限性

  • 基于动物模型的临床前证据,向人类转化需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While antipsychotics primarily target dopamine D2 receptor, the putative synaptic mechanisms underlying their therapeutic effects remain unclear. Postsynaptic density (PSD) at glutamatergic synapses represents a dynamic protein network involved in synaptic plasticity and neurotransmission, whose dysfunction has been implicated in the pathophysiology of schizophrenia and bipolar disorder. This study aims to explore, for the first time, with a quantitative meta-analytical approach, how antipsychotic treatments affect PSD molecules across various brain regions in preclinical settings, which may overcome the heterogeneity of human studies. METHODS: We systematically reviewed and meta-analyzed peer-reviewed preclinical studies reporting quantitative effects of typical and atypical antipsychotics on PSD-related outcomes. Statistical analyses used random-effects models, with heterogeneity assessed via τ², I², and Cochran's Q. Separate meta-analyses were conducted for PSD protein type, brain region, animal type, and treatment paradigms. Meta-regressions assessed the impact of cofounding variables. RESULTS: We included 81 studies (n = 2542; rodents=2510; monkeys=26), resulting in 226 meta-analyses. Both typical and atypical antipsychotics modulated PSD molecules albeit with different degree due to the drug receptor profile, dose, specific protein detected, brain region, and administration regimen. Haloperidol, amisulpride, and aripiprazole significantly increased PSD protein expression in the striatum. Acute olanzapine increased PSD molecules levels in striatal regions, reducing Arc expression in frontal cortex (SMD [95%CIs]=-2.15 [-2.7;-1.61], p < 0.0001); chronic treatment had opposite effects. Clozapine increased Homer1a levels in dorsal (1.13 [0.41;1.86], p = 0.002) and ventral striatum (1.48 [0.72;2.24], p = 0.0001), and cingulate cortex (2.12 [1.12;3.12], p < 0.0001), as well as increased NMDAR subunits levels in frontal cortex.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. De Simone G, De Prisco M, Oliva V, et al. Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications. Mol Psychiatry. 2025. PMID: 41258376. doi:10.1038/s41380-025-03351-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。